Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Finasteride does not prevent bladder cancer.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Best results found using acetonitrile, water, and trifluoroacetic acid or methanol mixture.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

The method accurately measures vitamin E compounds in capsules.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Grape pomace can be used to make valuable products with antioxidants and tocopherols.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Certain natural compounds called terpenes may help prevent prostate cancer.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

A group has developed therapies that show promise for treating cancer and various other conditions.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Early balding at 40 increases prostate cancer risk.